September 24, 2018

Adcetris May Increase Risk of Lung Toxicity in Younger Hodgkin’s Lymphoma Patients, Study Suggests

News

Adcetris (brentuximab vedotin) treatment may increase the chances of lung toxicity in children and young adults with relapsed or refractory Hodgkin’s lymphoma, a small retrospective study suggests. The study, “Pulmonary ... Read more

July 26, 2018

Velcade-based Therapy Effective in Certain East Asian Mantle Cell Lymphoma Patients, Study Finds

News

A treatment combination including Velcade (bortezomib) was seen to be more effective than the standard R-CHOP chemotherapy in East Asian patients with mantle cell lymphoma (MCL) who cannot undergo a stem ... Read more